Search












The lists contain medicinal products or product categories subject to prescription which shall not bear the safety features (White list) and medicinal products or product categories not subject to prescription which shall bear the safety features (Black list)
Number of records: 6509
Name of the medicinal product Supplement
SÚKL code Registration Number SPC ? PIL ? ATC group MA status ?
DAFIRO HCT 10MG/320MG/25MG TBL FLM 280(20X14)
0167196 EU/1/09/574/060 dafirohct.pdf dafirohct.pdf C09DX01 R
DAFIRO HCT 5MG/160MG/12,5MG TBL FLM 14
0167137 EU/1/09/574/001 dafirohct.pdf dafirohct.pdf C09DX01 R
DAFIRO HCT 5MG/160MG/12,5MG TBL FLM 28
0167138 EU/1/09/574/002 dafirohct.pdf dafirohct.pdf C09DX01 R
DAFIRO HCT 5MG/160MG/12,5MG TBL FLM 30
0167139 EU/1/09/574/003 dafirohct.pdf dafirohct.pdf C09DX01 R
DAFIRO HCT 5MG/160MG/12,5MG TBL FLM 56
0167140 EU/1/09/574/004 dafirohct.pdf dafirohct.pdf C09DX01 R
DAFIRO HCT 5MG/160MG/12,5MG TBL FLM 90
0167141 EU/1/09/574/005 dafirohct.pdf dafirohct.pdf C09DX01 R
DAFIRO HCT 5MG/160MG/12,5MG TBL FLM 98
0167142 EU/1/09/574/006 dafirohct.pdf dafirohct.pdf C09DX01 R
DAFIRO HCT 5MG/160MG/12,5MG TBL FLM 280(20X14)
0167143 EU/1/09/574/007 dafirohct.pdf dafirohct.pdf C09DX01 R
DAFIRO HCT 5MG/160MG/12,5MG TBL FLM 56X1
0167144 EU/1/09/574/008 dafirohct.pdf dafirohct.pdf C09DX01 R
DAFIRO HCT 5MG/160MG/12,5MG TBL FLM 98X1
0167145 EU/1/09/574/009 dafirohct.pdf dafirohct.pdf C09DX01 R
DAFIRO HCT 5MG/160MG/12,5MG TBL FLM 280X1
0167146 EU/1/09/574/010 dafirohct.pdf dafirohct.pdf C09DX01 R
DAFIRO HCT 5MG/160MG/12,5MG TBL FLM 280X1(4X70)
0167147 EU/1/09/574/011 dafirohct.pdf dafirohct.pdf C09DX01 R
DAFIRO HCT 5MG/160MG/12,5MG TBL FLM 280(20X14)
0167148 EU/1/09/574/012 dafirohct.pdf dafirohct.pdf C09DX01 R
DAFIRO HCT 10MG/160MG/12,5MG TBL FLM 14
0167149 EU/1/09/574/013 dafirohct.pdf dafirohct.pdf C09DX01 R
DAFIRO HCT 10MG/160MG/12,5MG TBL FLM 28
0167150 EU/1/09/574/014 dafirohct.pdf dafirohct.pdf C09DX01 R
DAFIRO HCT 10MG/160MG/12,5MG TBL FLM 30
0167151 EU/1/09/574/015 dafirohct.pdf dafirohct.pdf C09DX01 R
DAFIRO HCT 10MG/160MG/12,5MG TBL FLM 56
0167152 EU/1/09/574/016 dafirohct.pdf dafirohct.pdf C09DX01 R
DAFIRO HCT 10MG/160MG/12,5MG TBL FLM 90
0167153 EU/1/09/574/017 dafirohct.pdf dafirohct.pdf C09DX01 R
DAFIRO HCT 10MG/160MG/12,5MG TBL FLM 98
0167154 EU/1/09/574/018 dafirohct.pdf dafirohct.pdf C09DX01 R
DAFIRO HCT 10MG/160MG/12,5MG TBL FLM 280
0167155 EU/1/09/574/019 dafirohct.pdf dafirohct.pdf C09DX01 R

‹‹ ‹ 30 40 50 60 70 74 75 76 77 78 79 80 81 82 83 84 90 100 110 120 130 200 300 › ››

Medicinal products reimbursed from health insurance are blue-tinged and marked with sign.

Medicinal products on the Czech market in line with periodical report from wholesalers in last 3 months (with monthly distance) are sign and are typed in bold

Last update of registration information: 18. May 2021 at 01:08
Last update of price and payment data: 1. May 2021 at 01:14